Continuing Medical Education: Online CME: Rheumatology CME: An Update in Treatments for Osteoporosis and Osteonecrosis of the Jaw: Case Studies and Discussion: National Association of Continuing Education (NACE): Oct. 23, 2008 - Oct. 22, 2010
http://www.cmenetworks.com/cme/11577/1/Continuing-Medical-Education-Online-CME-Rheumatology-CME-An-Update-in-Treatments-for-Osteoporosis-and-Osteonecrosis-of-the-Jaw-Case-Studies-and-Discussion-National-Association-of-Continuing-Education-NACE-Oct-23-2008---Oct-22-2010-/Page1.html
National Association for Continuing Education (NACE)
The mission of the National Association for Continuing Education (NACE) is to offer continuing education opportunities to provide learners in the fields of medicine, behavioral health, education, and related disciplines, with the most up-to-date, science-based information that will enable them to maintain or increase their knowledge, skills, and professional performance to ultimately benefit the public’s health.
By National Association for Continuing Education (NACE)
Published on 05/27/2010
An Update for the Treatment of Osteoporosis and Osteonecrosis of the Jaw: Case Studies and Discussion
National Association for Continuing Education (NACE)
Oct. 23, 2008 - Oct. 22, 2010
This webcast was captured live at the NACE New Perspectives in the Management of Rheumatic Diseases: Update 2008 conference and features Dr. Michael Maricic. Dr. Maricic is Clinical Associate Professor of Medicine and the University of Arizona and Co-Director of Catalina Pointe Arthritis and Rheumatology Specialists, PC in Tucson, AZ.
CME Sponsor:
National Association of Continuing Education (NACE)
Location:
Online
Course Directors:
(Disclosures Listed)
Michael Maricic, MD made the following disclosures: Consultant/Speaker – Novartis, P&G, Lilly, Roche, GSK, Amgen, Merck
Alan Brown, MD, Course Director, made the following disclosure: Speaker’s Bureau - Abbot
Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose.
Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Number of Credits:
1 AMA PRA Category 1 Credits™
Registration Fee:
Free
More Info
Detailed Description:
An Update for the Treatment of Osteoporosis and Osteonecrosis of the Jaw: Case Studies and Discussion
National Association for Continuing Education (NACE)
Oct. 23, 2008 - Oct. 22, 2010
This webcast was captured live at the NACE New Perspectives in the Management of Rheumatic Diseases: Update 2008 conference and features Dr. Michael Maricic. Dr. Maricic is Clinical Associate Professor of Medicine and the University of Arizona and Co-Director of Catalina Pointe Arthritis and Rheumatology Specialists, PC in Tucson, AZ.
An Update for the Treatment of Osteoporosis and Osteonecrosis of the Jaw: Case Studies and Discussion
CME Sponsor:
National Association of Continuing Education (NACE)
Location:
Online
Course Directors:
(Disclosures Listed)
Michael Maricic, MD made the following disclosures: Consultant/Speaker – Novartis, P&G, Lilly, Roche, GSK, Amgen, Merck
Alan Brown, MD, Course Director, made the following disclosure: Speaker’s Bureau - Abbot
Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose.
Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Number of Credits:
1 AMA PRA Category 1 Credits™
Registration Fee:
Free
More Info
Detailed Description:
This webcast was captured live at the NACE New Perspectives in the Management of Rheumatic Diseases: Update 2008 conference and features Dr. Michael Maricic. Dr. Maricic is Clinical Associate Professor of Medicine and the University of Arizona and Co-Director of Catalina Pointe Arthritis and Rheumatology Specialists, PC in Tucson, AZ.
Course Objectives:
Upon completion of this program, learners should be able to:
- Discuss and implement current guidelines for the assessment, diagnosis and treatment of osteoporosis and osteonecrosis of the jaw
- Explain the mechanism of action, safety, and efficacy of therapies